Related Experiment Video
Updated: Jul 2, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.1K
Is the Validity of Logistic Regression Models Developed with a National Hospital Database Inferior to Models
Alain Bernard1, Jonathan Cottenet2, Catherine Quantin2,3
1Department of Thoracic and Cardiovascular Surgery, Dijon University Hospital, 21000 Dijon, France.
Cancers
|February 24, 2024
Summary
French hospital databases offer comparable prognostic model performance to specialized clinical databases like Epithor. However, hospital models may lack crucial clinical variables for improved accuracy.
Area of Science:
- Medical Informatics
- Health Services Research
- Clinical Epidemiology
Background:
- National hospital databases often lack detailed prognostic factors.
- Evaluating the performance of predictive models across different data sources is crucial for clinical utility.
Purpose of the Study:
- To compare the performance of prognostic models developed using a specialized clinical database (Epithor) versus a national French hospital database.
- To assess the impact of data source limitations on model accuracy and calibration.
Main Methods:
- Two datasets (Epithor and French hospital database) were used, with 70% for training and 30% for validation.
- Model performance was evaluated using Brier score, Area Under the Receiver Operating Characteristic (AUC ROC) curve, and calibration plots.
- Predictors included FEV1, BMI, ASA score, and TNM stage in the Epithor model.
Main Results:
- Both models demonstrated similar Brier scores.
- The AUC ROC for the hospital database (0.8) was slightly higher than for Epithor (0.73) on validation data.
- Calibration plots showed a slope less than 1 for both databases, indicating potential over-prediction.
Conclusions:
- Prognostic models derived from national hospital databases show performance comparable to specialized databases.
- National databases may not capture essential clinical variables (e.g., FEV1, ASA, TNM stage), potentially limiting model precision.
- Further research is needed to integrate comprehensive clinical data into national databases for enhanced predictive accuracy.
Related Concept Videos
Statistical Methods for Analyzing Epidemiological Data
366
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
366
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Cancer Survival Analysis
346
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
346
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122

